| 发明名称 |
ANVENDELSE AF STATHMIN SOM BIOMARKØR FOR LÆGEMIDDELRESPONS PÅ FURAZANOBENZIMIDAZOLER |
| 摘要 |
Use of stathmin as a biomarker for predicting the response, such as resistance, to a compound, wherein the compound is a furazanobenzimidazole compound of general formula (I). |
| 申请公布号 |
DK2666015(T3) |
申请公布日期 |
2017.03.27 |
| 申请号 |
DK20120700827T |
申请日期 |
2012.01.19 |
| 申请人 |
Basilea Pharmaceutica AG |
发明人 |
LANE, Heidi Alexandra;BACHMANN, Felix |
| 分类号 |
G01N33/50;A61K31/00 |
主分类号 |
G01N33/50 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
